Skip to main content
CELLULAR GOODS PLC logo

CELLULAR GOODS PLC — Investor Relations & Filings

Ticker · CBX ISIN · GB00BK964W87 LEI · 213800IXPX4Z2MKX2U28 IL Manufacturing
Open in API
Filings indexed 232 across all filing types
Latest filing 2022-03-14 Regulatory Filings
Country GB United Kingdom
Listing IL CBX

About CELLULAR GOODS PLC

https://cellular-goods.com/

Cellular Goods PLC is a wellness company focused on developing consumer products using lab-grown, biosynthetic cannabinoids. The company's initial product lines included high-end skincare and topical athletic recovery solutions, utilizing cannabinoids like Cannabidiol (CBD) produced via cellular agriculture. This method aims to provide high-purity and sustainable ingredients. In early 2024, the company announced a strategic shift to focus on artificial intelligence applications within the beauty sector, leading to a proposed name change to Cel AI PLC.

Recent filings

Filing Released Lang Actions
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1933 characters) and contains the header 'RNS Number : 7088E'. It discusses a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange. The text explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates it is a general regulatory announcement distributed via the RNS system, rather than a specific financial report like an ER, 10-K, or IR. Since it is a general regulatory announcement that doesn't fit the other specific categories (like DIRS, DIV, or DLST), the most appropriate fallback category is Regulatory Filings (RNS).
2022-03-14 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document is very short (1916 characters) and announces a 'Price Monitoring Extension' related to trading on the London Stock Exchange, referencing the RNS system. It explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure—a brief announcement about a market event or regulatory update distributed via the RNS system—fits best under the general Regulatory Filings category, as it is not a specific financial report (like 10-K, ER, or IR) nor a specific corporate action like a dividend or director dealing. Given the context of being distributed by RNS and not being a primary financial report, RNS is the most appropriate classification.
2022-03-14 English
Launch of outdoor marketing campaign
Report Publication Announcement Classification · 99% confidence The document is identified by the header 'RNS Number : 5846E' and contains a 'Press release' dated 14 March 2022. The content announces the launch of an outdoor marketing campaign, which is a general business update, not a specific financial filing like a 10-K, ER, or IR. The footer explicitly states, 'This information is provided by Reach, the non-regulatory press release distribution service of RNS...' and 'Reach announcements are identified with an orange label...'. Since this is a general, non-regulatory press release distributed via the RNS system that does not fit into any other specific category (like DIRS, DIV, CAP, etc.), the most appropriate classification is the general regulatory/news announcement fallback category, RNS.
2022-03-14 English
Share purchase by CEO
Director's Dealing Classification · 100% confidence The document is an official announcement disseminated via RNS (Number: 0287E) on March 8, 2022. The core content details the purchase of ordinary shares by the CEO, Anna Chokina, identifying her as a Person Discharging Managerial Responsibilities (PDMR). This type of filing, which reports personal share transactions by directors and executives, directly corresponds to the definition of Director's Dealing. The specific code for this is DIRS.
2022-03-08 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1933 characters) and contains the header 'RNS Number : 8586D' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' which is a specific operational announcement related to trading halts or volatility controls on the exchange. This type of brief, operational regulatory update that doesn't fit into specific financial reporting categories (like 10-K, ER, or DIV) is best classified as a general Regulatory Filing, which corresponds to the RNS category, or potentially a Report Publication Announcement (RPA) if it were announcing a report. Since this is a direct operational notice from the exchange system (RNS), the most appropriate category is RNS (Regulatory Filings) as the fallback for miscellaneous regulatory announcements.
2022-03-07 English
Price Monitoring Extension
Share Issue/Capital Change Classification · 99% confidence The document is very short (1916 characters) and contains the header 'RNS Number : 8563D' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, brief operational announcement related to trading mechanics, not a comprehensive financial report or a formal regulatory filing like a 10-K or IR. Since it is a general regulatory announcement that doesn't fit the specific categories (like DIV, DIRS, ER, etc.), the most appropriate classification is the general regulatory filing fallback category, RNS.
2022-03-07 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.